Immunolocalisation of the VEGF receptors FLT-1, KDR, and FLT-4 in diabetic retinopathy. - Wikidata - wikimedia - TriplyDB

Immunolocalisation of the VEGF receptors FLT-1, KDR, and FLT-4 in diabetic retinopathy.

Immunolocalisation of the VEGF receptors FLT-1, KDR, and FLT-4 in diabetic retinopathy.

http://www.wikidata.org/entity/Q30750084

about

The absence of diabetic retinopathy in patients with retinitis pigmentosa: implications for pathophysiology and possible treatment Glucose, VEGF-A, and diabetic complications The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology.Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy.Multiple receptor tyrosine kinases are expressed in adult rat retinal ganglion cells as revealed by single-cell degenerate primer polymerase chain reaction.Vascular endothelial growth factor-B gene transfer exacerbates retinal and choroidal neovascularization and vasopermeability without promoting inflammation.Optos-guided pattern scan laser (Pascal)-targeted retinal photocoagulation in proliferative diabetic retinopathy.Tissue inhibitor of metalloproteinases-3 peptides inhibit angiogenesis and choroidal neovascularization in mice The pathogenesis of diabetic retinopathy: old concepts and new questions.Arginase in retinopathy.Vasoreparative dysfunction of CD34+ cells in diabetic individuals involves hypoxic desensitization and impaired autocrine/paracrine mechanisms.Oxidative stress in retinal pigment epithelium cells increases exosome secretion and promotes angiogenesis in endothelial cells.Vascular endothelial growth factor C promotes survival of retinal vascular endothelial cells via vascular endothelial growth factor receptor-2.A chronic grey matter penumbra, lateral microvascular intussusception and venous peduncular avulsion underlie diabetic vitreous haemorrhage Vascular endothelial growth factor in eye disease.Early trials of angiogenic factors have not targeted patients most at risk of ocular disease.Blockade of vascular endothelial growth factor receptor 1 prevents inflammation and vascular leakage in diabetic retinopathy.The role of vascular endothelial growth factor in the progression of diabetic vascular complications.Identification of angiotensin converting enzyme 2 in the rodent retina.

P2860

Q28353997-B0DCE2F0-9C51-47A2-AD60-AAACC40DA11E Q28362039-99AFED96-B405-4398-B691-A48AAD8974E8 Q30733285-299DDC13-C907-433C-9D11-0C1360684150 Q31065469-691319C6-1239-47D6-A29C-EECB2BB7308C Q33784188-631E254E-C8C3-4AFD-B8EE-C6608CBAF278 Q33834038-1EC0F3E6-ACA1-409E-9EC0-7437BBD50424 Q34103851-8BA488A2-9E24-4838-824A-1BBAEE16EA06 Q34612933-B196A06B-DA0B-47A7-BAF9-69A4DC575FEF Q34658478-8C2E2B25-AC6A-410C-8E64-BE0F2F389E2E Q34800913-E691F8DC-5506-496D-AC20-A4765156E4CA Q35142725-3FBE652B-BDDD-4645-B132-BAFD9767EDB7 Q35964977-81A0EEA1-8D3B-440F-B8F1-1AE67D3A7372 Q36014743-9848204B-DF3A-4F31-8ADA-A8DBCE3B02F0 Q36796695-507AABF1-710E-4F68-95B4-4802A2E796A2 Q36929380-B6085D8A-8A1C-439E-87C7-C6B09ED3D1E6 Q42111999-32EB8DBE-950C-4B7F-BB34-A2A48858F6C4 Q42123271-CFF19CD3-4CAD-419C-B180-331ECB21ADD5 Q43051921-2A8AE6D3-7F4B-4EC6-AEBC-793E773FA171 Q46374769-BC4A75F3-8F66-42F0-9DE5-4148BEDF0928

P2860

Immunolocalisation of the VEGF receptors FLT-1, KDR, and FLT-4 in diabetic retinopathy.

http://www.wikidata.org/entity/Q30750084

description

1999 nî lūn-bûn

@nan

1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Immunolocalisation of the VEGF receptors FLT-1, KDR, and FLT-4 in diabetic retinopathy.

@ast

Immunolocalisation of the VEGF receptors FLT-1, KDR, and FLT-4 in diabetic retinopathy.

@en

type

label

Immunolocalisation of the VEGF receptors FLT-1, KDR, and FLT-4 in diabetic retinopathy.

@ast

Immunolocalisation of the VEGF receptors FLT-1, KDR, and FLT-4 in diabetic retinopathy.

@en

prefLabel

Immunolocalisation of the VEGF receptors FLT-1, KDR, and FLT-4 in diabetic retinopathy.

@ast

Immunolocalisation of the VEGF receptors FLT-1, KDR, and FLT-4 in diabetic retinopathy.

@en

P1433

Q30750084-D3A9D2AA-7D79-4CD7-8D4B-95DB5B686822

P1476

Q30750084-A407C976-1E5F-4516-BF7A-C42DC793CF1D

P2093

Q30750084-19C7F569-B64F-4497-B5DD-F94C9CC9D0F5

Q30750084-858D40D3-F3F2-44E2-9425-B489B8790E95

Q30750084-EB6D91A9-6BD1-47A1-AC94-B01E7D7D2AA1

Q30750084-ED5BED68-9C95-4590-9D0C-3C8E791FFCAB

P2860

Q30750084-01835558-532C-4478-9F7A-C932C9558EB4

Q30750084-0465D794-5FE9-411B-8B26-38FC216EB7DA

Q30750084-0E554A59-71D0-48FA-93C5-DCFCD6BF2390

Q30750084-0E97333A-3AD3-4D50-9127-9D24AAB195D5

Q30750084-16223B54-C4A7-4B7F-88B1-B849F7D3B448

Q30750084-21A64B34-F734-49D2-B020-155430E04347

Q30750084-396EB2CB-E11A-449C-9529-66538C9A8AE0

Q30750084-3F77365C-D4C7-4361-B5C4-52A9926DD286

Q30750084-449D96A6-2E25-4C11-A11B-CA8D0D097470

Q30750084-50AA336D-329F-4728-A4A5-A32F6C8BF412

P304

Q30750084-C4FF7881-AB49-4255-A1E5-35BC2713D95B

P31

Q30750084-612C2096-3302-4B6C-B820-637EC10344D4

P356

Q30750084-61726043-4EBB-49D0-8885-6274188D7525

P407

Q30750084-FD179427-35BF-4F1D-8033-CC3F5F4B8A60

P433

Q30750084-F1DA4838-572E-434C-AC37-BA808D668147

P478

Q30750084-DDDF787F-400B-4498-8B2E-39106BFE3BAA

P577

Q30750084-A5109E5B-90BC-4C1F-A338-6E59F5158006

P5875

Q30750084-79263462-F745-4692-B93C-B26BCBEBE13A

P698

Q30750084-6D3CB9E0-17BA-4AE0-873D-95C4CC00747E

P932

Q30750084-0608913A-019B-4199-BAF8-66E129845F7C

P356

P1433

British Journal of Ophthalmology

P1476

Immunolocalisation of the VEGF receptors FLT-1, KDR, and FLT-4 in diabetic retinopathy.

@en

P2093

Boulton M

http://www.w3.org/2001/XMLSchema#string

Foreman D

http://www.w3.org/2001/XMLSchema#string

McLeod D

http://www.w3.org/2001/XMLSchema#string

Smith G

http://www.w3.org/2001/XMLSchema#string

P2860

Biochemical characterization of two isoforms of FLT4, a VEGF receptor-related tyrosine kinase

Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases

The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor

Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium

Vascular endothelial growth factor and its receptors, flt-1 and flk-1, are expressed in normal pancreatic islets and throughout islet cell tumorigenesis

High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis

VEGF localisation in diabetic retinopathy.

Increased expression of placenta growth factor in proliferative diabetic retinopathy.

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.

P304

486-494

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BJO.83.4.486

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P577

1999-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12864653

http://www.w3.org/2001/XMLSchema#string

P698

10434875

http://www.w3.org/2001/XMLSchema#string

P932

1722996

http://www.w3.org/2001/XMLSchema#string